DOD Biotech PCL (BKK:DOD)

DOD Biotech PCL Revenue

DOD Biotech PCL had revenue of 122.55M THB in the quarter ending March 31, 2026, a decrease of -29.26%. This brings the company's revenue in the last twelve months to 570.53M, down -14.18% year-over-year. In the year 2025, DOD Biotech PCL had annual revenue of 621.21M, down -6.17%.

• Revenue (ttm): 570.53M
• Revenue Growth: -14.18%
• P/S Ratio: 1.29
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 738.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	621.21M	-40.82M	-6.17%
Dec 31, 2024	662.04M	-30.67M	-4.43%
Dec 31, 2023	692.71M	144.38M	26.33%
Dec 31, 2022	548.33M	-470.01M	-46.15%
Dec 31, 2021	1.02B	-61.57M	-5.70%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error